Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Graham

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
Hybridoma|August 1, 1993
Isolation and characterization of monoclonal antibodies to a recombinant human topoisomerase II polypeptideR G Robinson, L Rapp, K J Bowdish, et al.
Hematological Oncology|March 1, 1993
Pharmacokinetics of high dose methylprednisolone and use in hematological malignanciesP M Patel, P J Selby, M A Graham, et al.
Journal of the National Cancer Institute|April 1, 1992
Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation schemeM A Graham, D Bissett, A Setanoians, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 7, 2000
Validation of a highly sensitive ICP-MS method for the determination of platinum in biofluids: application to clinical pharmacokinetic studies with oxaliplatinJ G Morrison, P White, S McDougall, et al.
The American Journal of Forensic Medicine and Pathology|March 1, 1997
Criteria for the diagnosis of heat-related deaths: National Association of Medical Examiners. Position paper. National Association of Medical Examiners Ad Hoc Committee on the Definition of Heat-Related FatalitiesE R Donoghue, M A Graham, J M Jentzen, et al.
Cancer Research|February 1, 1992
Clinical pharmacokinetics of the anthrapyrazole CI-941: factors compromising the implementation of a pharmacokinetically guided dose escalation schemeM A Graham, D R Newell, B J Foster, et al.
Emerging Infectious Diseases|December 17, 2016
Sequence Analysis of Toxin Gene-Bearing Corynebacterium diphtheriae Strains, AustraliaChristine J Doyle, Adam Mazins, Rikki M A Graham, et al.
Anti-Cancer Drug Design|April 1, 1996
The pharmacokinetics, bioavailability and biodistribution in mice of a rationally designed 2-nitroimidazole hypoxia probe SR-4554E O Aboagye, A D Lewis, M A Graham, et al.
British Journal of Cancer|December 1, 1996
In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022H L McLeod, V G Brunton, N Eckardt, et al.
Heredity|August 6, 2015
Iterative development and the scope for plasticity: contrasts among trait categories in an adaptive radiationS A Foster, M A Wund, M A Graham, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Hybridoma|August 1, 1993
Isolation and characterization of monoclonal antibodies to a recombinant human topoisomerase II polypeptideR G Robinson, L Rapp, K J Bowdish, et al.
Hematological Oncology|March 1, 1993
Pharmacokinetics of high dose methylprednisolone and use in hematological malignanciesP M Patel, P J Selby, M A Graham, et al.
Journal of the National Cancer Institute|April 1, 1992
Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation schemeM A Graham, D Bissett, A Setanoians, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 7, 2000
Validation of a highly sensitive ICP-MS method for the determination of platinum in biofluids: application to clinical pharmacokinetic studies with oxaliplatinJ G Morrison, P White, S McDougall, et al.
The American Journal of Forensic Medicine and Pathology|March 1, 1997
Criteria for the diagnosis of heat-related deaths: National Association of Medical Examiners. Position paper. National Association of Medical Examiners Ad Hoc Committee on the Definition of Heat-Related FatalitiesE R Donoghue, M A Graham, J M Jentzen, et al.
Cancer Research|February 1, 1992
Clinical pharmacokinetics of the anthrapyrazole CI-941: factors compromising the implementation of a pharmacokinetically guided dose escalation schemeM A Graham, D R Newell, B J Foster, et al.
Emerging Infectious Diseases|December 17, 2016
Sequence Analysis of Toxin Gene-Bearing Corynebacterium diphtheriae Strains, AustraliaChristine J Doyle, Adam Mazins, Rikki M A Graham, et al.
Anti-Cancer Drug Design|April 1, 1996
The pharmacokinetics, bioavailability and biodistribution in mice of a rationally designed 2-nitroimidazole hypoxia probe SR-4554E O Aboagye, A D Lewis, M A Graham, et al.
British Journal of Cancer|December 1, 1996
In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022H L McLeod, V G Brunton, N Eckardt, et al.
Heredity|August 6, 2015
Iterative development and the scope for plasticity: contrasts among trait categories in an adaptive radiationS A Foster, M A Wund, M A Graham, et al.
Pageof 12